As of September 1, 2022, Patrick Glassman, PhD will join the Department of Pharmaceutical Sciences faculty as Assistant Professor.

Dr. Glassman comes to Temple from the Department of Systems Pharmacology and Translational Therapeutics at the University of Pennsylvania where he served as a Research Associate. In this role, he applied his broad expertise in mechanism-based PK/PD modeling of biologics, protein engineering, and development of targeted drug therapy systems. He has developed several novel protein constructs with tunable binding and pharmacokinetic properties, with great impact on drug delivery to the sites of inflammation.

Dr. Glassman's productive scientific career began during his graduate training under the direction of Joseph Balthaser, PhD at the University at Buffalo Department of Pharmaceutical Sciences. There, his dissertation research was focused on the development of predictive, physiologically-based pharmacokinetic models for monoclonal antibodies. During his postdoctoral training with Vladimir Muzykantov, PhD, a leading expert in vascular drug delivery, and during his current Research Associate position over the past five years, both experiences at Penn, Dr. Glassman was identified as a rising star and awarded a National Institutes of Health (NIH) K99/R00 Pathway to Independence Award application. He will transition this three-year award from the NIH National Heart, Lung, and Blood Institute for his project "FcRn-enabling strategies for improved thrombolytic therapy" to Temple.

Dr. Glassman has published over 20 manuscripts in high impact journals, presented numerous abstracts, and was invited to present his work at national and international scientific meetings. He holds Doctor of Philosophy and Bachelor of Science degrees in Pharmaceutical Sciences from the University at Buffalo, The State University of New York.